+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Results for tag: "Checkpoint Inhibitors"

From
From
From
From
From
From
Malignant Mesothelioma Market Report 2025 - Product Thumbnail Image

Malignant Mesothelioma Market Report 2025

  • Report
  • May 2025
  • 175 Pages
  • Global
From
Testicular Cancer Market Report 2025 - Product Thumbnail Image

Testicular Cancer Market Report 2025

  • Report
  • April 2025
  • 175 Pages
  • Global
From
From
From
Personalized Cancer Treatment Market Report 2025 - Product Thumbnail Image

Personalized Cancer Treatment Market Report 2025

  • Report
  • April 2025
  • 200 Pages
  • Global
From
From
Laryngeal Cancer Therapeutics Market Report 2025 - Product Thumbnail Image

Laryngeal Cancer Therapeutics Market Report 2025

  • Report
  • March 2025
  • 200 Pages
  • Global
From
Non-Small Cell Lung Cancer (NSCLC) Market Report 2025 - Product Thumbnail Image

Non-Small Cell Lung Cancer (NSCLC) Market Report 2025

  • Report
  • March 2025
  • 200 Pages
  • Global
From
Intestine Cancer Therapeutics Market Report 2025 - Product Thumbnail Image

Intestine Cancer Therapeutics Market Report 2025

  • Report
  • March 2025
  • 200 Pages
  • Global
From
CAR-T Therapy Market Report 2025 - Product Thumbnail Image

CAR-T Therapy Market Report 2025

  • Report
  • March 2025
  • 175 Pages
  • Global
From
Immuno-Oncology Drugs Market Report 2025 - Product Thumbnail Image

Immuno-Oncology Drugs Market Report 2025

  • Report
  • March 2025
  • 250 Pages
  • Global
From
Loading Indicator

The Checkpoint Inhibitors market is a subset of the Oncology Drugs market, which focuses on treatments for cancer. Checkpoint Inhibitors are a type of immunotherapy, which works by blocking certain proteins that act as “checkpoints” in the body’s immune system. By blocking these checkpoints, the body’s immune system is able to recognize and attack cancer cells. This type of therapy has been found to be effective in treating a variety of cancers, including melanoma, non-small cell lung cancer, and bladder cancer. The Checkpoint Inhibitors market is highly competitive, with many companies developing and marketing their own products. Some of the major players in the market include Merck, Bristol-Myers Squibb, Roche, AstraZeneca, and Pfizer. Show Less Read more